IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Einmahl, S.
Right arrow Articles by Gurny, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Einmahl, S.
Right arrow Articles by Gurny, R.
(Investigative Ophthalmology and Visual Science. 2001;42:695-700.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

A New Poly(Ortho Ester)-Based Drug Delivery System as an Adjunct Treatment in Filtering Surgery

Suzanne Einmahl1, Francine Behar–Cohen2, François D’Hermies2, Serge Rudaz3, Cyrus Tabatabay1, Gilles Renard2 and Robert Gurny1

1 From the Department of Pharmaceutical Technology and Biopharmaceutics and the 2 Department of Pharmaceutical Analytical Chemistry, School of Pharmacy, University of Geneva, Switzerland; and the 3 Department of Ophthalmology, Hôtel-Dieu Hospital, Paris, France.

PURPOSE. Pharmacologic modulation of wound healing after glaucoma filtering surgery remains a major clinical challenge in ophthalmology. Poly(ortho ester) (POE) is a bioerodible and biocompatible viscous polymer potentially useful as a sustained drug delivery system that allows the frequency of intraocular injections to be reduced. The purpose of this study was to determine the efficacy of POE containing a precise amount of 5-fluorouracil (5-FU) in an experimental model of filtering surgery in the rabbit.

METHODS. Trabeculectomy was performed in pigmented rabbit eyes. An ointmentlike formulation of POE containing 1% wt/wt 5-FU was injected subconjunctivally at the site of surgery, during the procedure. Intraocular pressure (IOP), bleb persistence, and ocular inflammatory reaction were monitored until postoperative day 30. Quantitative analysis of 5-FU was performed in the anterior chamber. Histologic analysis was used to assess the appearance of the filtering fistula and the polymer’s biocompatibility.

RESULTS. The decrease in IOP from baseline and the persistence of the filtering bleb were significantly more marked in the 5-FU–treated eyes during postoperative days 9 through 28. Corneal toxicity triggered by 5-FU was significantly lower in the group that received 5-FU in POE compared with a 5-FU tamponade. Histopathologic evaluation showed that POE was well tolerated, and no fibrosis occurred in eyes treated with POE containing 5-FU.

CONCLUSIONS. In this rabbit model of trabeculectomy, the formulation based on POE and containing a precise amount of 5-FU reduced IOP and prolonged bleb persistence in a way similar to the conventional method of a 5-FU tamponade, while significantly reducing 5-FU toxicity.




This article has been cited by other articles:


Home page
IOVSHome page
M. B. Polak, F. Valamanesh, O. Felt, A. Torriglia, J.-C. Jeanny, J.-L. Bourges, P. Rat, A. Thomas-Doyle, D. BenEzra, R. Gurny, et al.
Controlled Delivery of 5-Chlorouracil Using Poly(Ortho Esters) in Filtering Surgery for Glaucoma
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2993 - 3003.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Einmahl, M. Savoldelli, F. D'Hermies, C. Tabatabay, R. Gurny, and F. Behar-Cohen
Evaluation of a Novel Biomaterial in the Suprachoroidal Space of the Rabbit Eye
Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1533 - 1539.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology